Skip to main content

The Top 10 Most Important Articles of 2016 (and some from 2015)


This is a summary of a talk given by Drs. Krishan Yadav and Maggie Kisilewicz at the National Capital Conference in Emergency Medicine. Below are brief summaries and a bottom line, but of course you'll have to read the literature yourself to make your own decisions!

1) Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage ATACH-2 

Qureshi et al. N Engl J Med 2016; 375: 1033 – 1043.
DOI: 10.1056/NEJMoa1603460.

• RCT to assess if aggressive SBP reduction within 4.5 hours of spontaneous intracranial hemorrhage results in decreased death or disability at 3 months.
• Main Finding: No difference in death or disability at 3 months for Intensive BP (110 – 139 mmHg) vs. Standard BP (140 – 179 mmHg) group.
o Caution: this trial really compared SBP targets of 129 mmHg vs. 141 mmHg (see Figure 1)

• Bottom Line: BP reduction to 140 mmHg is safe. Aim for a SBP target of 160 mmHg in 
spontaneous ICH – if the patient continues to deteriorate, revise target to 140 mmHg.


2) An Age-Adjusted D-dimer Threshold of Emergency Department patients with Suspected Pulmonary Embolus: Accuracy and Clinical Implications. 

Sharp et al. Ann Emerg Med. 2016 Feb;67(2):249-57. 
DOI: 10.1016/j.annemergmed.2015.07.026

• Retrospective chart review to assess the sensitivity and specificity of using an age-adjusted D-dimer threshold to aid in diagnosing PE in patients 50 years or older.
• Main Finding: In older adults, the age-adjusted D-dimer threshold is more accurate. It is more specific (64% versus 54%) but less sensitive (93% versus 98%) than the standard threshold of 500 ng/dL resulting in less low value imaging.

• Bottom Line: Start using age adjusted D-dimer to evaluate older adults suspected of PE.

3) Discharge Glucose Is Not Associated With Short-Term Adverse Outcomes in Emergency Department Patients With Moderate to Severe Hyperglycemia. 

Driver et al. Ann Emerg Med. 2016 December; 68(6): 697-705.
DOI: http://dx.doi.org/10.1016/j.annemergmed.2016.04.057.

• Retrospective cohort study to determine if ED patients with moderate to severe hyperglycemia suffer adverse outcomes at 7 days (return to ED, admission, DKA, or HHS)
• Main Finding: could not find any association between discharge glucose level or treating hyperglycemia (IVF +/- insulin) and 7-day adverse events
o Caution: consider correcting hyperglycemia in the patient being discharged with an infection

• Bottom Line: in uncomplicated hyperglycemia (no DKA/HHS or infection), do not administer IVF or insulin to lower blood glucose to an arbitrary ‘safe’ level. Instead, focus on ensuring appropriate follow-up for long-term glycemic control.

4) Air Versus Oxygen in ST-Segment–Elevation Myocardial Infarction. 

Stub D. et al. Circulation. 2015 Jun16;131(24):2143-50. 
DOI: 0.1161/CIRCULATIONAHA.114.014494.

• Multicenter RCT to determine if administering air or supplemental oxygen to normoxic STEMI patients undergoing PCI affected infarct size as assessed by cardiac enzyme rise and by cardiac MRI 6 months post infarct.
• Main Finding: Supplemental oxygen resulted in statistically higher peak creatinine kinase but not troponin-I. After 6 months, patients receiving supplemental oxygen had larger areas of infarct on cMRI. There was statistical increase in the rates of re-infarction and arrhythmias in patients receiving oxygen, however the study was not powered for these clinical end-points.

• Bottom Line: Supplemental oxygen administered to normoxic STEMI patients has not shown to be beneficial and may, in fact, increase myocardial injury


5) Randomized Clinical Trial of Observation versus Antibiotic Treatment for a First Episode of CT Proven Uncomplicated Acute Diverticulitis (DIABOLO). 

Daniels et al. Br J Surg 2016; 104: 52 – 61.
DOI: 10.1002/bjs.10309.

• Multicenter RCT to determine if antibiotics versus observation leads to decreased time to recovery during 6 months of follow-up.
• Main Finding: antibiotics did not improve time to recovery for first-episode uncomplicated diverticulitis. In addition, there was no benefit for multiple secondary outcomes (readmission rates, development of complicated diverticulitis, need for surgery)
o Caution: 8% of trial participants had an abscess < 5 cm; these patients should still get antibiotics

• Bottom Line: Use shared decision making with carefully selected patients (can get GP follow-up, tolerating PO intake, no fever) regarding outpatient antibiotics for uncomplicated diverticulitis.


6) Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting. 

Patel et al. JAMA Intern Med. 2016 Jul 1;176(7):981-8. 
DOI:10.1001/jamainternmed.2016.1509.

• Retrospective cohort looking at whether hospital referral is safer than routine outpatient management for ambulatory patients with asymptomatic hypertension (>180/100).
• Main Finding: In this study of 58 535 patients, emergency department visits for hypertensive urgency were associated with higher rates of hospital admission but not major cardiac events when compared with patients who were sent home. The rate of major adverse cardiac events was less than 1% in all patients. Two-thirds of patients still had uncontrolled hypertension at 6 months.

• Bottom Line: ED visits for hypertensive urgency are associated with more resource utilization but not better CV outcomes.

7) Immediate Total-Body CT Scanning Versus Conventional Imaging and Selective CT Scanning in Patients with Severe Trauma (REACT-2): A Randomized Controlled Trial. 

Sierink et al. Lancet 2016; 388(10045): 673 – 683. 
DOI: 10.1016/S0140-6736(16)30932-1.

• Published data to date suggests pan-can is associated with improved survival – but all studies have been retrospective. This is the first RCT to determine if pan-scan for trauma is associated with decreased in-hospital mortality.
• Main Finding: No difference between pan-scan versus selective-scan groups for in-hospital mortality.
o Caution: 46% of patients in selective-scan group ended up with the equivalent of a pan-scan during hospital stay

• Bottom Line: There is still no consensus on which trauma patients actually benefit from a pan-scan.

8) Immediate Discharge and Home Treatment With Rivaroxaban of Low Risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: A One-year Preplanned Analysis. 

Beam et al. Acad Emerg Med. 2015 Jul;22(7):788-95. 
DOI: 10.1111/acem.12711.

• In this prospective observational study, 106 low-risk PE and DVT patients were started on rivaroxaban and sent home directly from the ED. Outpatient clinic follow up occurred within 36h of discharge. Outcomes included VTE recurrence, bleeding complications and medication compliance over a 6 month period. Patient and physician satisfaction was not measured.
• Main Findings: No patients developed recurrent or new VTE while on treatment and there were no major bleeding events. Overall patient compliance was 92%.

• Bottom Line: Selected low-risk patients diagnosed with VTE can be safely started on DOAC therapy and discharged from the ED to close outpatient follow up.

9) A randomized trial of intraarterial treatment for acute ischemic stroke. 

Berhamer et al. N Engl J Med. 2015 Jan 1;372(1):11-20. 
DOI: 10.1056/NEJMoa1411587.

• In this pragmatic, multicenter RCT, 500 patients with disabling ischemic stroke localized to the anterior circulation artery were randomized to intra-arterial treatment plus usual care or usual care alone.
• Main Finding: Absolute difference of 13.5 percentage points in good neurologic outcome (modified Rankin Score 0 – 2) favouring the intervention group. This corresponds to an NNT = 8. No increase in mortality or symptomatic ICH was seen.

• Bottom Line: Intra-arterial therapy within 6 hours of symptom onset improved functional independence at 90days.

10) Prevalence of Pulmonary Embolism Among Patients Hospitalized for Syncope (PESIT). 

Prandoni et al. N Engl J Med 2016; 375: 1542 – 1531.
DOI: 10.1056/NEJMoa1602172.

• Cross-sectional multicenter study to determine the prevalence of pulmonary embolism (PE) among patients hospitalized for syncope.
• Main Finding: overall prevalence for PE = 17.3% (“approximately 1 in 6 patients hospitalized for syncope had a PE”)
o Caution: cause and effect not established. This does not mean 1 in 6 patients had syncope because of a PE.

• Bottom Line: Do not change current clinical practice. Patients with syncope should be worked up for PE when it is felt to be clinically warranted.




Comments

Popular posts from this blog

Tips for Success in your Emergency Medicine Rotation

Our wonderful medical students are preparing to start their first clinical rotations. With this in mind here are some of the top tips for success in your EM rotation
1)Be On Time – show up to your shifts on time, better yet 5 minutes early.That first impression is immensely important.
2)Introduce yourself to the team - “Hi my name is John Doe, I am the medical student on shift today” introduce yourself to the attending, residents, nurses, etc.You will be called on a lot more to help when there is something interesting going on if they know your name.
3)Be goal-oriented – have a goal for each shift, whether it’s a procedure or a type of presentation to see.
4)Don’t just stand there, do something – whenever there is a trauma or code, come to the bedside.Get gowned up for traumas and pay attention.Help with things that are within your scope of practice: chest compressions, moving patient, cardioversion
5)Don’t just stand there, do nothing – there are times in medicine when the best thing to d…

2014 Canadian Guidelines for AF Management: Part 1: Introduction and CCS “CHADS-65” Algorithm

by Ian Stiell MD @EMO_Daddy














In this and subsequent postings we will discuss the latest recommendations for ED management of atrial fibrillation (AF) as presented in the newly published 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. The Guidelines PDF can be downloaded from the CCS website at 2014 Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
The 2014 Focused Update uses the GRADE system of evidence evaluation as was the case in the comprehensive 2010 AF Guidelines and the 2012 Update. The CCS AF Guidelines Panel is comprised of Canadian cardiologists plus physicians from internal medicine, family medicine, neurology, and emergency medicine. This 2014 Update provides evidence review and recommendations for 8 aspects of AF care, including ED Management (written by myself and Dr. Laurent Macle of the Montreal Heart Institute). The 2014 Update focuses on advances in oral anticoagulant (O…

You CAN reverse that! Reversal of NOAC's and more..

We have seen a large surge of the utilization of New Oral Anticoagulants (NOAC's) in the past few years, as such, it has been a novel challenge when these patients present to the Emergency Department (ED) with life threatening bleeding. Dr. Michael Ho looks to discuss treatment options, and future options in these patients. 
NOACs vs WarfarinDabigatran, Rivaroxaban and Apixaban have seen a dramatic increase in use since their approval in Canada. Dabigatran is a direct thrombin (Factor II) inhibitor, while the latter two are direct Xa inhibitors. These drugs are collectively referred to as novel oral anticoagulants (NOACs). They have also been called direct, or target-specific oral anticoagulants (DOACs or TSOACs) [1]. 
The NOACs have many practical advantages over warfarin: Rapid onset of actionShorter half-lifeLess food and drug interferencePredictable pharmacokineticsEase of use and no requirement for monitoringThe downsides to NOACs are the higher cost to the patient, the inabilit…